title: Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice.
authors.forename: Aly S
authors.initials: AS
authors.lastname: Abdel-Mageed
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Senagore
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Pietryga
authors.forename: Robert H
authors.initials: RH
authors.lastname: Connors
authors.forename: Troy A
authors.initials: TA
authors.lastname: Giambernardi
authors.forename: Rick V
authors.initials: RV
authors.lastname: Hay
authors.forename: Weiwen
authors.initials: W
authors.lastname: Deng
mesh_terms: D000818:Animals; D005260:Female; D005720:Gamma Rays / Q000009:adverse effects*; D005818:Genetic Engineering; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000201:enzymology*; D051379:Mice; D008807:Mice, Inbred BALB C; D039902:Multipotent Stem Cells / Q000201:enzymology*; D011833:Radiation Injuries, Experimental / Q000201:enzymology / Q000235:genetics / Q000628:therapy*; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*; D014916:Whole-Body Irradiation
chemical_list: D013482:Superoxide Dismutase